Jose Luis
Alonso Romero
Asociado Ciencias de la Salud
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Hospital General Universitario Gregorio Marañón (2)
2022
-
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Lung Cancer, Vol. 173, pp. 83-93
-
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 6, pp. 1107-1116